BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3967844)

  • 21. [Contribution of plasma C-peptide to the classification of sugar diabetes in Dakar, Senegal].
    Cisse A; Chevenne D; Chauffert M; Diop Diouf RM; Diop SN; Sidibe EH; Sow AM; Trivin F
    Dakar Med; 1997; 42(1):11-4. PubMed ID: 9827110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Random C-peptide in the classification of diabetes.
    Berger B; Stenström G; Sundkvist G
    Scand J Clin Lab Invest; 2000 Dec; 60(8):687-93. PubMed ID: 11218151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are young age and insulin treatment enough to diagnose IDDM?
    Maislos M; Weitzman S
    Diabetes Care; 1997 Apr; 20(4):675-6. PubMed ID: 9097003
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical significance of C-peptide.
    Rubenstein AH; Gonen B
    Adv Exp Med Biol; 1979; 124():15-28. PubMed ID: 506831
    [No Abstract]   [Full Text] [Related]  

  • 25. Arresting type 1 diabetes after diagnosis: GAD is not enough.
    Mathieu C; Gillard P
    Lancet; 2011 Jul; 378(9788):291-2. PubMed ID: 21715000
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201.
    Shields BM; Henley W; Besser RE; Hattersley AT; Ludvigsson J
    Diabetes Care; 2013 Dec; 36(12):e222. PubMed ID: 24265391
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201.
    Chaudhary S; Thukral A; Kataria M; Ghosh S; Mukherjee S; Chowdhury S
    Diabetes Care; 2013 Dec; 36(12):e221. PubMed ID: 24265390
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of hyperglycaemia in the elderly with diabetes mellitus.
    Madsbad S
    J Intern Med; 1990 Aug; 228(2):79-82. PubMed ID: 2203874
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of IDDM in adults in the community.
    Maislos M; Weitzman S
    Diabetes Care; 1995 Jun; 18(6):885-6. PubMed ID: 7555523
    [No Abstract]   [Full Text] [Related]  

  • 30. C-peptide: a redundant relative of insulin?
    Luzi L; Zerbini G; Caumo A
    Diabetologia; 2007 Mar; 50(3):500-2. PubMed ID: 17225123
    [No Abstract]   [Full Text] [Related]  

  • 31. Dead or alive?
    Greenbaum CJ
    Diabetes Care; 2012 Mar; 35(3):459-60. PubMed ID: 22355015
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporin in diabetes.
    Koivisto VA; Pelkonen R
    Lancet; 1985 Feb; 1(8425):401. PubMed ID: 2857455
    [No Abstract]   [Full Text] [Related]  

  • 33. Depleting T cells in newly diagnosed autoimmune (type 1) diabetes--are we getting anywhere?
    Lernmark Å
    Diabetes; 2013 Nov; 62(11):3669-70. PubMed ID: 24158996
    [No Abstract]   [Full Text] [Related]  

  • 34. Dasiglucagon Hydrochloride.
    Am J Health Syst Pharm; 2021 Jul; 78(15):1351-1353. PubMed ID: 33998648
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    Eur J Pediatr; 2008 Jul; 167(7):801-5. PubMed ID: 17874132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discrimination of type I from insulin-treated type II diabetic patients by C-peptide measurement.
    Cravarezza P; Radaeli E; Toffoli C; Rigosa C
    Acta Diabetol Lat; 1986; 23(4):345-50. PubMed ID: 3564834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.
    Yamanouchi T; Akanuma H; Nakamura T; Akaoka I; Akanuma Y
    Diabetologia; 1988 Jan; 31(1):41-5. PubMed ID: 3350220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
    Kan Y; Chi Z
    Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.